OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cellular immunotherapies and immune cell depleting therapies in inflammatory bowel diseases: the next magic bullet?
Markus F. Neurath, Bruce E. Sands, Florian Rieder
Gut (2024) Vol. 74, Iss. 1, pp. 9-14
Closed Access | Times Cited: 6
Markus F. Neurath, Bruce E. Sands, Florian Rieder
Gut (2024) Vol. 74, Iss. 1, pp. 9-14
Closed Access | Times Cited: 6
Showing 6 citing articles:
Histone deacetylase in inflammatory bowel disease: novel insights
Chunxiao Li, Shaobo Gu, Yihong Zhang, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access
Chunxiao Li, Shaobo Gu, Yihong Zhang, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access
A new therapeutic pathway in autoimmune diseases: chimeric antigen receptor T cells (CAR-T) targeting specific cell subtypes or antigen-specific B lymphocytes—a brief review
María Fernanda Segovia, Diana Landoni, Yohana Defranchi, et al.
Exploration of Immunology (2025) Vol. 5
Open Access
María Fernanda Segovia, Diana Landoni, Yohana Defranchi, et al.
Exploration of Immunology (2025) Vol. 5
Open Access
Causal Characteristics of Immune Cells Associated with Aortic Dissection: A Mendelian Randomisation Analysis
Tian-le Li, M.J. Fu, Lihong Wang, et al.
European Cardiology Review (2025) Vol. 20
Open Access
Tian-le Li, M.J. Fu, Lihong Wang, et al.
European Cardiology Review (2025) Vol. 20
Open Access
Exploiting regulatory T cells (Tregs): Cutting-edge therapy for autoimmune diseases
Marwa Hassan, Mohamed Elzallat, Dina Mostafa Mohammed, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114624-114624
Open Access
Marwa Hassan, Mohamed Elzallat, Dina Mostafa Mohammed, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114624-114624
Open Access
Diverse potential of chimeric antigen receptor‐engineered cell therapy: Beyond cancer
Lvying Wu, Lingfeng Zhu, Jin Chen
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access
Lvying Wu, Lingfeng Zhu, Jin Chen
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access
IL-23R-Specific Chimeric Antigen Receptor Tregs in Crohn’s Disease: Dawn of a Cellular Immunotherapeutic Era?
Raja Atreya, Markus F. Neurath
Journal of Crohn s and Colitis (2024)
Closed Access
Raja Atreya, Markus F. Neurath
Journal of Crohn s and Colitis (2024)
Closed Access
PD-1 agonist: A novel therapeutic approach to resolve atherosclerosis
Jiahui Chen, Wei Yu, Le Liao, et al.
Results in Chemistry (2024) Vol. 12, pp. 101892-101892
Open Access
Jiahui Chen, Wei Yu, Le Liao, et al.
Results in Chemistry (2024) Vol. 12, pp. 101892-101892
Open Access
From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases
Yannick Bulliard, Robert A. Freeborn, Molly Javier Uyeda, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Yannick Bulliard, Robert A. Freeborn, Molly Javier Uyeda, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
